Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models
Authors:
- On behalf of the SBC/EPICURO Study InvestigatorsOIOn behalf of the SBC/EPICURO Study Investigators
- A. PicornellAPA. Picornell
- A. TardónATA. Tardón
- J. LloretaJLJ. Lloreta
Open Access
- 3 June 2016
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 16 (1) , 1-9
Abstract
We adapted Bayesian statistical learning strategies to the prognosis field to investigate if genome-wide common SNP improve the prediction ability of clinico-pathological prognosticators and applied it to non-muscle invasive bladder cancer (NMIBC) patients. Adapted Bayesian sequential threshold models in combination with LASSO were applied to consider the time-to-event and the censoring nature of data. We studied 822 NMIBC patients followed-up >10 years. The study outcomes were time-to-first-recurrence and time-to-progression. The predictive ability of the models including up to 171,304 SNP and/or 6 clinico-pathological prognosticators was evaluated using AUC-ROC and determination coefficient. Clinico-pathological prognosticators explained a larger proportion of the time-to-first-recurrence (3.1 %) and time-to-progression (5.4 %) phenotypic variances than SNPs (1 and 0.01 %, respectively). Adding SNPs to the clinico-pathological-parameters model slightly improved the prediction of time-to-first-recurrence (up to 4 %). The prediction of time-to-progression using both clinico-pathological prognosticators and SNP did not improve. Heritability (ĥ 2) of both outcomes was <1 % in NMIBC. We adapted a Bayesian statistical learning method to deal with a large number of parameters in prognostic studies. Common SNPs showed a limited role in predicting NMIBC outcomes yielding a very low heritability for both outcomes. We report for the first time a heritability estimate for a disease outcome. Our method can be extended to other disease models.Keywords
Funding Information
- Instituto de Salud Carlos III (#PI06-1614, #PI00-0745)
- Fundación Científica Asociación Española Contra el Cáncer
- Seventh Framework Programme (EU-7FP-HEALTH-TransBioBC #601933, EU-FP7-HEALTH-F2-2008-201663-UROMOL)
- European Urological Scholarship Program for Research (S-01-2013)
- Red Temática de Investigación Cooperativa en Cáncer ((#RD12/0036/0050)
- Instituto de Saludo Carlos III (#PI05-1436)
- Intramural Research Program, Division of Cancer Epidemiology and Genetics (NCI NO2-CP-11015)
This publication has 29 references indexed in Scilit:
- A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future ChallengesAdvances in Urology, 2012
- EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 UpdateEuropean Urology, 2011
- Beyond Missing Heritability: Prediction of Complex TraitsPLOS Genetics, 2011
- Genetic Variations in the Sonic Hedgehog Pathway Affect Clinical Outcomes in Non–Muscle-Invasive Bladder CancerCancer Prevention Research, 2010
- Common SNPs explain a large proportion of the heritability for human heightNature Genetics, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Performance of Common Genetic Variants in Breast-Cancer Risk ModelsNew England Journal of Medicine, 2010
- Predicting Quantitative Traits With Regression Models for Dense Molecular Markers and PedigreeGenetics, 2009
- Economic aspects of bladder cancer: what are the benefits and costs?World Journal of Urology, 2009
- Genetic relationship of discrete-time survival with fertility and production in dairy cattle using bivariate modelsGenetics Selection Evolution, 2007